| McGill, Stephen (Sequana Medical 201404– VP Sales + Marketing before Angiodynamics et al) |
Sales Manager / Marketing Manager |
Sequana Medical (Group) |
Switzerland |
| McGinley, Michael (Phenomenex 201105 HPLC Product Manager) |
Product Manager (personnel) |
Danaher (Group) |
United States (USA) |
| McGrath, Donnie (BMS 201511 VP Business Development) |
Business Development Manager / Strategy Manager |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| McGregor, Laura (Schauenburg 201710– Product Marketing Manager at SepSolve before Product Marketing Manager at Markes) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| McGuinness, Ina (Rx Communications 201904) |
Public Relations Manager / Investor Relations Manager |
Rx Communications Group LLC (RxIR) |
United States (USA) |
| McGuire, Mike (Roche 200610 VP anti-infectives) |
n. a. |
Roche (Group) |
Switzerland |
| McIntire, Chris (ITT Corp 201009 President ITT Analytics) |
President/Director/Head Business Group/Unit/Division |
Xylem (Group) |
United States (USA) |
| McIntosh, Barbara (Scienion 2018– President Scienion US before HyperTeknologies LLC 201610 CEO before BioDot) |
President/Director/Head Business Group/Unit/Division |
Bico (Group) |
United States (USA) |
| McKernan, Kevin (Courtagen 201206 CSO before Agencourt CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Courtagen Life Sciences Inc. |
United States (USA) |
| McKernan, R. Brian (Agencourt 200308 CEO) |
Chief Executive Officer (CEO) |
Courtagen Life Sciences Inc. |
United States (USA) |
| McLaren, John (Dinaqor 202009– Chairman of Dynacor Ltd former British diplomat, investment banker + venture capitalist) |
Board member |
Dinaqor (Group) |
United Kingdom (GB) |
| McLean, Andrew (Univ Oxford 201906 Head of Life Sciences 201712 Principal at Oxford Sciences Innovation) |
IP Manager |
Oxford Science Enterprises (Group) |
United Kingdom (GB) |
| McMillan, Daniel (Danaher 201712 Business Development Manager at Sciex) |
n. a. |
Danaher (Group) |
United Kingdom (GB) |
| McMullen, Mike (Agilent 201409– COO + designated CEO for 3/15 before SVP + President Chemical Analysis Group) |
Chief Operating Officer (COO) |
Agilent (Group) |
United States (USA) |
| McNamara, Brian (GSK 201609– CEO of Consumer Healthcare division before Novartis + Procter & Gamble) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
| McNamara, Peter (Tectonic Therapeutic 202005– before Genomics Institute of Novartis Research Foundation since 2005) |
Research & Development Manager |
Tectonic Therapeutic Inc. |
United States (USA) |
| McNamara, Phil (Bayer 202303 VP Corporate Communications at AskBio) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
United States (USA) |
| Meade, Jennifer (Hologic 202101 Division President Breast + Skeletal Health Solutions) |
President/Director/Head Business Group/Unit/Division |
Hologic (Group) |
United States (USA) |
| Meadows-Smith, Marcus (AgraQuest 201207 CEO) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
| Mechtler, Karl (Research Institute for Molecular Pathology IMP 201311 Head of Protein Chemistry Facility) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
IMP |
|
| Medeiros, Paul (Purdue Pharma 201708 SVP Corp + Business Develompent at Mundipharma) |
Business Development Manager / Strategy Manager |
Purdue Pharma (Group) |
United Kingdom (GB) |
| Meder, Bernhard (M-Invest GmbH 2013 Managing Director) |
Managing Director |
M-Invest GmbH |
Germany |
| Meek, David (Ferring 202001– CEO of FerGene before Ipsen + Baxalta + Endocyte + Novartis + JnJ) |
Chief Executive Officer (CEO) |
Ferring (Paulsen Foundation) (Group) |
United States (USA) |
| Mégret, Dominique (Swisscom 201901 Head of Swisscom Ventures) |
President/Director/Head Business Group/Unit/Division |
Swisscom (Group) |
Switzerland |
| Mehl, Konstantin (Kaia Health 202006 Managing Director) |
Managing Director |
Kaia Health (Group) |
Germany |
| Mehler, Michael (AXA 201208 CEO of Riemser Pharma before Actelion + Novartis) |
Chief Executive Officer (CEO) |
Esteve (Group) |
Germany |
| Mehrabanzad, Arya (Ampersand 202203 VP at Ampersand Capital Partners) |
n. a. |
Ampersand Capital Partners, Amsterdam |
Netherlands |
| Mehrling, Thomas (Purdue Pharma 201708 CEO of Mundipharma EDO GmbH) |
Chief Executive Officer (CEO) |
Purdue Pharma (Group) |
Switzerland |
| Mehta, Sunil (kSep Systems 201606 CEO) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
United States (USA) |
| Mehtali, Majid (Valneva –201308 CSO before Vivalis since 2003 + Deltagen Europe + Crucell DIED 8/13) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Valneva (Group) |
France |
| Meiboom, Meike (ZytoVision 200705 Scientist) |
n. a. |
ZytoVision (Group) |
Germany |
| Meier, Klaus (Blanke Meier Evers + Kompass Private Equity) |
n. a. |
Blanke Meier Evers |
Germany |
| Meier, Marc (Bosch 201804 General Manager of Bosch Healthcare Solutions) |
General Manager (management) |
Bosch (Group) |
Germany |
| Meier, Michael (Chromsystems 200907 Managing Director) |
Managing Director |
Chromsystems Instruments & Chemicals GmbH |
Germany |
| Meier, Roger (Versameb 201812 Board Chairman) |
Board member |
Versameb AG |
Switzerland |
| Meier, Simon (VI Partners 202206– Partner Healthcare before Roche Diagnostics Information Solution + Roche Venture Fund) |
Partner (venture partner) |
VI Partners AG |
Switzerland |
| Meier, Thomas (Viopas Venture Consulting 202201 Managing Partner before Santhera Pharmaceuticals) |
Board member, non-executive |
Viopas Venture Consulting (VVC) (Group) |
Switzerland |
| Meier, Ulf (Niedersachsen (govt) 2023202 Board Member at NBank) |
Board member |
Niedersachsen (govt region) |
Germany |
| Meier-Ewert, Sebastian (MPM Capital 201207– Managing Director Munich + KI Kapital before GPC Biotech) |
Managing Director |
MPM Capital (Group) |
Germany |
| Meier-Pfister, Martin (Speedel 200809) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Switzerland |
| Meijer, Martijn (Ncardia 201712 CFO) |
Chief Financial Officer (CFO) |
Kiniciti Bio (WCAS invesment platform) (Group) |
Belgium |
| Meinel, Christoph (Hasso Plattner Institute 201211 Director + Prof at Univ Potsdam) |
President/Director/Head Business Group/Unit/Division |
Hasso-Plattner-Institut für Softwaresystemtechnik GmbH (HPI, Hasso Plattner Institute) |
Germany |
| Meissner, Victoria (BioNTech 202308 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Germany |
| Meister, Ralf (business angel) |
n. a. |
PERSON |
|
| Meister, Robert (Selexis 201511 Head Corporate + Marketing Communications) |
Public Relations Manager / Investor Relations Manager |
JSR Corporation (Group) |
Switzerland |
| Meitinger, Thomas |
n. a. |
Humangenomprojekt (DE) |
Germany |
| Meißner, Matthias (Co.don 201405 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
ReLive (Group) |
Germany |
| Mekiffer, Beate (WISTA-Management GmbH 201503 Head of Strategic Projects) |
Business Development Manager / Strategy Manager |
WISTA-Management GmbH (Innovations- und GründerZentrum Berlin Adlershof) |
Germany |
| Melcher, Michaela (World Trade Group LEFT SUMMER 2013) |
Sales Manager / Marketing Manager |
World Trade Group Ltd. (WTG) |
United Kingdom (GB) |
| Melcher, Rebecca (Bex-Biotec 201803 Managing Director + Founder) |
Managing Director |
Bex-Biotec (Group) |
Germany |
| Meldrum, Eric (Enyo Pharma 201711 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Enyo Pharma S.A. |
France |
| Meldrum, Peter (Myriad 200511 CEO) |
Chief Executive Officer (CEO) |
Myriad Genetics (Group) |
United States (USA) |
| Melerzanov, Alexander (MIPT 201303 Dean of Dept of Molecular + Biological Physics) |
Professor |
Moscow Institute of Physics and Technology (MIPT) |
Russian Federation |
| Melin, Jessica (Sony 201112 Sr Manager Business Development + Sales North America at Sony DADC) |
Business Development Manager / Strategy Manager |
Sony (Group) |
Austria |
| Melingo, Michael (George James 20803– Managing Partner at George James GmbH before Sartorius 201404–201709 + Metrohm) |
Managing Partner |
George James (Group) |
Germany |
| Mello, Virginia (Securecell 202002 Marketing Manager) |
Sales Manager / Marketing Manager |
Securecell (Group) |
Switzerland |
| Melnik, Ted (Sumitomo 201503 EVP + COO of Valent BioSciences Corp) |
Chief Operating Officer (COO) |
Sumitomo (Group) |
United States (USA) |
| Melzer, Philipp (CMS Hasche Sigle 201511) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Mendel, Scott (GenMark Diagnostics 202103 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Mendivil, Carrie (Gilmartin Group 202102) |
Public Relations Manager / Investor Relations Manager |
Gilmartin Group LLC (Gilmartin IR) |
United States (USA) |
| Meng, Jessica (Delfi Diagnostics 202207– Chief Commercial Officer before Myovant Sciences + Veracyte + Genentech) |
Chief Commercial Officer (CCO) |
Delfi Diagnostics Inc. |
United States (USA) |
| Meng, Zhang (Tencent 201901 VP of Tencent Medical) |
President/Director/Head Business Group/Unit/Division |
Tencent (00700.HK) |
China |
| Menichella, Daniel L. (Dan) (Kaleido Biosciences 202010– CEO before CureVac + Bamboo Therapeutics + AGTC + Zyngenia) |
Chief Executive Officer (CEO) |
Kaleido Biosciences Inc. (Nasdaq: KLDO) |
United States (USA) |
| Menne, Jan (Phenos GmbH 201201 Managing Director) |
Managing Director |
Phenos GmbH |
Germany |
| Menne, Simone (Boehringer Ingelheim 201609–201712 Managing Director responsible for Finance LEFT 12/17) |
Chief Financial Officer (CFO) |
Boehringer Ingelheim (Group) |
Germany |
| Menne, Tobias (Bayer 201702 Head of Digital Farming) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Mennenga-Klopp, Erk (Hamamatsu 200810 Head Medical Solutions Dept Hamamatsu Germany) |
n. a. |
Hamamatsu (Group) |
Germany |
| Mennenöh, Henning (Weitnauer 201104– before MLawGroup + Hogan & Hartson Raue LLP) |
Attorney / Lawyer |
Weitnauer Partnerschaft mbB Rechtsanwälte Steuerberater |
Germany |
| Mennerich, Detlev (Boehringer Ingelheim 201604 Investment Manager at BIVF) |
Investment Manager |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Menrad, Andreas (Ablynx 201211 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanofi (Group) [since May 2011] |
Belgium |
| Menschaert, Gerben (BioLizard 201909 Co-Founder) |
Company Founder |
BioLizard N.V. |
Netherlands |
| Menten, Jörg (SphingoTec 202111–CCO before CeloNova + Vanguard AG + Kinetic Concepts former CFO of Boehringer Mannheim) |
Chief Commercial Officer (CCO) |
SphingoTec (Group) |
Germany |
| Menu, Philippe (Sophia Genetics 202002– CMO before McKinsey & Company) |
Chief Medical Officer (CMO) |
Sophia Genetics (Group) |
Switzerland |
| Menyes, Ulf (Enzymicals 202203– Advisor before CEO) |
Chief Executive Officer (CEO) |
Enzymicals AG |
Germany |
| Menzel, Christoph (Qiagen 200909 Senior Global Product Manager Automated Systems) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
| Menzel, Rosika (BioRepro GmbH 201101 Managing Director) |
Managing Director |
BioRepro GmbH |
Germany |
| Mercanzini, André (Aleva Neurotherapeutics 201108 CTO) |
Chief Technology/Technical Officer (CTO) |
Aleva Neurotherapeutics S.A. |
Switzerland |
| Mercier, David (Strammer 201704 CEO + Founder) |
Chief Executive Officer (CEO) |
Strammer (Group) |
France |
| Mercier, Ray (Thermo Fisher 201609 VP + General Manager Liquid Handling Consumables) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Mercker, Ute (Berlin (govt) 201111 Senior Investment Manager Life Science at IBB Beteiligungsges) |
Investment Manager |
Berlin (govt region) |
Germany |
| Meredith, Ian (Boston Scientific 201703 EVP + Global CMO) |
Chief Medical Officer (CMO) |
Boston Scientific (Group) |
United States (USA) |
| Merget, Oliver (ABB 201006 ABB Automation GmbH Sales Chemical Solutions) |
Sales Manager / Marketing Manager |
ABB (Group) |
Germany |
| Merkel, Dirk (Miltenyi Biotech 201303 Licensing Manager Business Developm + Industrial Services) |
Business Development Manager / Strategy Manager |
Miltenyi Biotec (Group) |
Germany |
| Merkl, Bernd (Lophius 201510– Managing Director (Commercial Development) before Geneart 2005– BusDev Manager) |
Managing Director |
Mikrogen GmbH |
Germany |
| Merkle, Fritz (OHB-System 200902 Executive Board Director) |
Board member, executive |
Fuchs (Group) |
Germany |
| Merlot, Cédric (Drugdesigntech 2007– CEO + Founder before Serono since 2001 + Sanofi-Aventis) |
Chief Executive Officer (CEO) |
Drugdesigntech S.A. |
Switzerland |
| Merry, Garry (Sloning 200904– VP Commercial Operations before Bioneer Inc 200611 President) |
Sales Manager / Marketing Manager |
MorphoSys (Group) |
Germany |
| Mersmann, Sophia (Biotype Diagnostic 201107 Product Manager IVD) |
Product Manager (personnel) |
Molecular Diagnostics Group (MDG, family of Wilhelm Zörgiebel) (Group) |
Germany |
| Merten, Christoph (Velabs Therapeutics 201906 CSO + Scientific Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Veraxa Biotech (Group) |
Germany |
| Mertens, Christoph (Berlin Capital Fund 200504 Senior Investment Manager) |
Investment Manager |
Triginta Capital (Group) |
Germany |
| Mertens, Marianne (Apollo Health Ventures 202307 Partner + Booster Therapeutics before Wellington Partners) |
Partner (venture partner) |
Apollo Health Ventures (Group) |
Germany |
| Merz, Benedikt (PANATecs –201105c Managing Director) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Mescheder, Axel (Cristal Therapeutics 201811– CEO + CMO before MorphoSys/Lanthio + Medpace + TopoTarget + Medigene) |
Chief Executive Officer (CEO) |
Cristal Delivery B.V. (d/b/a/ Cristal Therapeutics) |
Netherlands |
| Messere, Suzanne (Precision Medicine Group 202209 at Stern IR) |
Public Relations Manager / Investor Relations Manager |
Precision Medicine Group (Group) |
United States (USA) |
| Messersmith, Mark (Biosun Biochemicals 202101 Chairman + Founder) |
Company Founder |
BRAIN Biotech (Group) |
United States (USA) |
| Metcalfe, Ian (NovaGo Therapeutics 202009– CEO before Corlieve Therapeutics + Roche + Nestlé Health Science) |
Chief Executive Officer (CEO) |
NovaGo Therapeutics AG |
Switzerland |
| Metea, Monica (Cyprotex 201609– Director of US Operations before Smithers Viscient + Covance Labs + WIL Research Labs) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
United States (USA) |
| Metges, Cornelia (Leibniz-Gemeinschaft 201109 FBN Dummerstorf Head Research Dept Ernährungsphysiologie) |
Researcher (university / research institute) |
Leibniz-Gemeinschaft |
Germany |
| Methnani, Fathia (MicroSafe 200507 Managing Director) |
Managing Director |
Eurofins (Group) |
Netherlands |
| Methner, Vilma (Co.don 201405 COO + CSO) |
Chief Operating Officer (COO) |
ReLive (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 49 50 51 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
